These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7750591)

  • 1. Medroxyprogesterone increases basal temperature: a placebo-controlled crossover trial in postmenopausal women.
    Prior JC; McKay DW; Vigna YM; Barr SI
    Fertil Steril; 1995 Jun; 63(6):1222-6. PubMed ID: 7750591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the central effects of different progestins used in hormone replacement therapy.
    Cagnacci A; Arangino S; Baldassari F; Alessandrini C; Landi S; Volpe A
    Maturitas; 2004 Aug; 48(4):456-62. PubMed ID: 15283939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No adverse effects of medroxyprogesterone treatment without estrogen in postmenopausal women: double-blind, placebo-controlled, crossover trial.
    Prior JC; Alojado N; McKay DW; Vigna YM
    Obstet Gynecol; 1994 Jan; 83(1):24-8. PubMed ID: 8272302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy in women with epilepsy: a randomized, double-blind, placebo-controlled study.
    Harden CL; Herzog AG; Nikolov BG; Koppel BS; Christos PJ; Fowler K; Labar DR; Hauser WA
    Epilepsia; 2006 Sep; 47(9):1447-51. PubMed ID: 16981859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of gonadotropin-releasing hormone agonist and medroxyprogesterone acetate on calcium metabolism: a prospective, randomized, double-blind, placebo-controlled, crossover trial.
    Carr BR; Breslau NA; Peng N; Adams-Huet B; Bradshaw KD; Steinkampf MP
    Fertil Steril; 2003 Nov; 80(5):1216-23. PubMed ID: 14607578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term medroxyprogesterone acetate in postmenopausal women with sleep-disordered breathing: a placebo-controlled, randomized, double-blind, parallel-group study.
    Anttalainen U; Saaresranta T; Vahlberg T; Polo O
    Menopause; 2014 Apr; 21(4):361-8. PubMed ID: 24253484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI.
    JAMA; 1996 Nov; 276(17):1389-96. PubMed ID: 8892713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Objective evidence that placebo and oral medroxyprogesterone acetate therapy diminish menopausal vasomotor flushes.
    Albrecht BH; Schiff I; Tulchinsky D; Ryan KJ
    Am J Obstet Gynecol; 1981 Mar; 139(6):631-5. PubMed ID: 7211966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women.
    Lindsay R; Gallagher JC; Kleerekoper M; Pickar JH
    Osteoporos Int; 2005 Apr; 16(4):372-9. PubMed ID: 15654581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF-I and ventilation after short-term progestin in postmenopausal women with chronic respiratory insufficiency.
    Saaresranta T; Irjala K; Polo-Kantola P; Helenius H; Polo O
    Respir Med; 2000 Sep; 94(9):909-16. PubMed ID: 11001085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory insufficiency in postmenopausal women: sustained improvement of gas exchange with short-term medroxyprogesterone acetate.
    Saaresranta T; Polo-Kantola P; Irjala K; Helenius H; Polo O
    Chest; 1999 Jun; 115(6):1581-7. PubMed ID: 10378552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged endocrine responses to medroxyprogesterone in postmenopausal women with respiratory insufficiency.
    Saaresranta T; Irjala K; Polo-Kantola P; Helenius H; Polo O
    Obstet Gynecol; 2000 Aug; 96(2):243-9. PubMed ID: 10908771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep parameters and health-related quality of life with bazedoxifene/conjugated estrogens: a randomized trial.
    Pinkerton JV; Pan K; Abraham L; Racketa J; Ryan KA; Chines AA; Mirkin S
    Menopause; 2014 Mar; 21(3):252-9. PubMed ID: 23942245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on haemostasis of hormone replacement therapy with transdermal estradiol and oral sequential medroxyprogesterone acetate: a 1-year, double-blind, placebo-controlled study. The Writing Group for the Estradiol Clotting Factors Study.
    Thromb Haemost; 1996 Mar; 75(3):476-80. PubMed ID: 8701411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
    Carr BR; Marshburn PB; Weatherall PT; Bradshaw KD; Breslau NA; Byrd W; Roark M; Steinkampf MP
    J Clin Endocrinol Metab; 1993 May; 76(5):1217-23. PubMed ID: 8496313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group.
    Archer DF; Pickar JH; Bottiglioni F
    Obstet Gynecol; 1994 May; 83(5 Pt 1):686-92. PubMed ID: 8164926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasomotor hot flashes and heart rate variability: a placebo-controlled trial of postmenopausal hormone therapy.
    Lantto H; Haapalahti P; Tuomikoski P; Viitasalo M; Väänänen H; Sovijärvi AR; Ylikorkala O; Mikkola TS
    Menopause; 2012 Jan; 19(1):82-8. PubMed ID: 21934534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose response effect of cyclical medroxyprogesterone on blood pressure in postmenopausal women.
    Harvey PJ; Molloy D; Upton J; Wing LM
    J Hum Hypertens; 2001 May; 15(5):313-21. PubMed ID: 11378833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of medroxyprogesterone on arterial blood gases, leptin and neuropeptide Y in postmenopausal females.
    Saaresranta T; Irjala K; Polo O
    Eur Respir J; 2002 Dec; 20(6):1413-8. PubMed ID: 12503697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.